Plastic electronics to bring “mind-blowing” developments for pharma

pharmafile | February 14, 2017 | News story | Manufacturing and Production, Research and Development plastic electronics 

Plastic electronics could be the next big thing for pharma production and treatment , according to a new report on the use of the tool in healthcare devices from IP licensable technology database InnovationDB.

Plastic electronics allow for the creation and printing of circuitry onto virtually any surface, be it rigid or flexible, using organic semiconducting materials. This opens up the development and application of electronic devices in areas which were not previously possible.

“Plastic electronics are a step change in the way we use electronics at every point of the product lifecycle,” explained InnovationDB CEO Gerald Law, allowing for a “mind-blowing array of new products and applications.”

According to the report, these applications cover a range of cutting-edge developments in the production, monitoring and treatment areas, including drug blister packs containing the technology which monitor and relay patient compliance to doctors in real time, and smart clothing or furniture which is able to monitor or even treat disease progression. The technology also enables breakthroughs such as a ‘smart skin’ which accelerates healing, bio-tattoos which can warn against heart attacks, and bio-sensors in the body which can prompt patients

“Although we’re not seeing fully developed in vivo bio-sensors just yet, it may be because the industry is taking small steps, to get things right and avoid overwhelming us,” Law added.

According to InnovationDB’s report, the market for the technology is due to grow from $26 billion last year to $69 billion in 2026, despite the infancy of the tool, with 3,000 organisations are already investing in the technology.

Matt Fellows

Related Content

No items found

Latest content